DNA vaccines

Bibliography

• WOLFF JA, DOWTY ME, RAO S et al: Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. J. Cell Science (1992)103:1249–1259.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates the special entry of naked DNA into muscle cells.
   Google Scholar
• WOLFF JA, LUDTKE JJ, ACSADI G, WILLIAMS P, JANI A: Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genetics (1992) 1:363–369.
   PubMedGoogle Scholar
• •A record of long duration of expression from episomal plasmids.
   Google Scholar
• ULMER JB, DONNELLY JJ, PARKER SE et al.: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 259:1745–1749.
   PubMed Web of Science ®Google Scholar
• WOLF JA, MALONE RW, WILLIAMS P et al: Direct gene transfer into mouse muscle in vivo. Science (1990) 247:1465–1468.
   PubMed Web of Science ®Google Scholar
• ••One of the principle studies initiating the advent of DNAvaccines.
   Google Scholar
• TORRES CAT, IWASAKI A, BARBER BH, ROBINSON HL: Differential dependence on target site tissue for gene gun and intramuscular DNA immunisations. J. Immunol. (1997) 158:4529–4532.
   PubMed Web of Science ®Google Scholar
• CORR M, LEE DJ, CARSON DA, TIGHE H: Gene vaccina-tion with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. (1996) 184:1555–1560.
   PubMed Web of Science ®Google Scholar
• •Important discussion of the routes of activation of T-cells by DNA vaccination.
   Google Scholar
• DOE B, SELBY M, BARNETT S, BAENZIGER J, WALKER CM: Induction of cytotoxic T lymphocytes by intramus-cular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl Acad. Sci. USA (1996) 93:8578–8583.
   PubMed Web of Science ®Google Scholar
• CESARES S, INABA K, BRUMEANU T-D, STEINMAN RM, BONA CA: Antigen presentation by dendritic cells after immunization with DNA encoding a major histocom-patibility complex class ffrestricted viral epitope. Exp. Med. (1997) 186:1481–1486.
   PubMed Web of Science ®Google Scholar
• PORGADOR A, IRVINE KR, IWASAKI A et al.: Predomi-nant role for directly transfected dendritic cels in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med. (1998) 188:1075–1082.
   PubMed Web of Science ®Google Scholar
• ••Establishment of the paarmount role of direct transfection ofdendritic cells by the gene gun.
   Google Scholar
• CORR M, TIGHE H: Plasmid DNA vaccination: mechanism of antigen presentation. Semin. Immunopa-thol. (1997) 19:139–145.
   PubMed Web of Science ®Google Scholar
• KREIG AM, YI AK, MATSON S, WALDSCHMIDT TJ et al.: CpG motifs in bacterial DNA trigger direct B-cell activa-tion. Nature (1995) 374:546–549.
   PubMed Web of Science ®Google Scholar
• ••Bacterial sequences cause direct stimulation of the humanimmune system.
   Google Scholar
• PISETSKY DS: The influence of base sequence on the immunostimulatory properties of DNA. Immunol Res. (1999) 19:35–46.
   PubMed Web of Science ®Google Scholar
• •Discussion of the influence of bases adjacent to the central immunostimulatory CpG motif.
   Google Scholar
• SPARWASSER T, HULTNER L, KOCH ES, LUZ A, LIPFORD G, WAGNER H: Immunostimulatory CpG-oligonucleotides casue extramedulary murine hemopoiesis. j Immunol. (1999) 162:2368–2374.
   PubMed Web of Science ®Google Scholar
• SEDEGAH M, HEDSTROM R, HOBART P, HOFFMAN SL: Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. ScL USA (1994) 91:9866–9870.
   PubMed Web of Science ®Google Scholar
• TOBERY TW, SILICIANO RF: Targeting of HIV-1 antigensfor rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. (1997) 185:909–920.
   PubMed Web of Science ®Google Scholar
• XIANG Z, ERTL HC: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity (1995) 2:129–135.
   PubMed Web of Science ®Google Scholar
• •Immune stimulation of DNA vaccines can be augmented by insertion of cytokine genes.
   Google Scholar
• CHOW YH, HUANG WL, CHI WK, CHU YD, TAO MH: Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. j Virol. (1997) 71:169–178.
   PubMed Web of Science ®Google Scholar
• KIM JJ, AYYAVO0 V, BAGARAZZI ML et al.: In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. (1997) 158:816–826.
   Google Scholar
• KIM JJ, BAGARAZZI ML, TRIVEDI N et al.: Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nature Biotechnol (1997) 15:641–646.
   PubMed Web of Science ®Google Scholar
• ANDERSON ED, MOURICH DV, FAHRENKRUG SC et al:Genetic immunization of rainbow trout (Oncorhyn-chus mykiss) against infectious hematopoietic necrosis virus. Mol. Marine Biol. Biotechnol. (1996) 5:114–122.
   PubMedGoogle Scholar
• XU L, SANCHEZ A, YANG Z et al: Immunization forEbola virus infection. Nature Med. (1998) 4:37–42.
   PubMed Web of Science ®Google Scholar
• WALKER PS, SCHARTON-KERSTEN T, ROWTON ED et al.:Genetic immunization with glycoprotein 63 cDNA results in helper T cell Type 1 immune response and protection in a murine model of leishmaniasis. Hum. Gene Ther. (1998) 9:1899–1907.
   PubMed Web of Science ®Google Scholar
• BARNETT SW, RAJASEKAR S, LEG H et al.: Vaccinationwith 11IV-1 gp120 DNA induces immune reponses that are boosted by a recombinant gp120 protein subunit. Vaccine (1997) 15:869–873.
   PubMed Web of Science ®Google Scholar
• DEML L, SCHIRMBECK R, REIMANN J, WOLF H, WAGNER R: Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1gp 160 envelope proteins. Chn. Chem.Lab. Med. (1999) 37:199–204.
   PubMed Web of Science ®Google Scholar
• HADDAD D, LILJEQVIST S, STAHL S et al.: Characteriza-tion of antibody resposes to Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol. Scand. J. Immunol (1999) 49:506–514.
   PubMed Web of Science ®Google Scholar
• HANKE T, SAMUEL RV, BLANCHARD TJ et al: Effectiveinduction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J. Vim]. (1999) 73:7524–7532.
   Web of Science ®Google Scholar
• SHNEIDER J, GILBERT SC, HANNAN CM et al: Induction of CD8+ T cells using heterologous prime-boost immunisation strategies. Immunol. Rev. (1999) 170:29–38.
   PubMed Web of Science ®Google Scholar
• BROIDE D, SCHWARZE J, TIGHE H et al.: Immunostimu- latory DNA sequences inhibit IL-5, eosinophylic inflamation and airway hyperresponsiveness in mice. Immunol (1998) 161:7054–7062.
   Web of Science ®Google Scholar
• ••Displacement of imflammatory responses by CpG motifs,vaccination can improve allergic diseases.
   Google Scholar
• GERLONI M, BALIOU WR, BILLETTA R, ZANETTI M: Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization. Nature Biotechnol. (1997) 15:876–881.
   PubMed Web of Science ®Google Scholar
• SIZEMORE DR, BRANSTROM AA, SADOFF JC: Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science (1995) 270:299–302.
   PubMed Web of Science ®Google Scholar
• GRILLOT-COURVALIN C, GOUSSARD S, HUERTZ F, OJICIUS DM, COURVALIN P: Functional gene transfer from intracellular bacteria to mammalian cells. Nature Biotechnol. (1998) 16:862–866.
   PubMed Web of Science ®Google Scholar
• DIETRICH G, BUBERT A, GENTSCHEV I et al.: Delivery ofantigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocyto-genes. Nature Biotechnol. (1998) 16:181–185.
   PubMed Web of Science ®Google Scholar
• FYNAN EF, WEBSTER RG, FULLER DH, HAYNES JR, SANTORO JC, ROBINSON HL: DNA vaccines: protective immunizations by parenteral, mucosal and gene gun inoculations. Proc. Natl Acad. Sci. USA (1993) 90:11478–11482.
   PubMed Web of Science ®Google Scholar
• •Comparison of iv., oral and gene gun vaccination.
   Google Scholar
• FYNAN EF, WEBSTER RG, FULLER DH, HAYNES JR, SANTORO JC, ROBINSON HL: DNA vaccines: a novel approach to immunisation. Int. J. Immunopharmacol. (1995) 17:79–83.
   PubMed Web of Science ®Google Scholar
• MCCLUSKIE MJ, BRAZOLOT-MILAN CL, GRAMZINSKI RA et al.: Route and method of delivery of DNA vaccine influence immune resonses in mice and non-human primates. AM. Med. (1999) 5:287–300.
   Google Scholar
• JOHNSTON SA, BARRY MA: Genetic to genomic vaccina-tion. Vaccine (1997) 15:808–809
   PubMed Web of Science ®Google Scholar
• BARRY MA, LAI WC, JOHNSTON SA: Protection against Mycoplasma infection using Expression-Library Immunisation. Nature (1995) 377:632–635.
   PubMed Web of Science ®Google Scholar
• DA VILLA G, PELLICCIA MG, PELUSO F, RICCIARDI E, SEPE A: Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine. Res. Virol. (1997) 148:109–114.
   PubMedGoogle Scholar
• MACGREGOR RR, BOYER JD, UGEN KE et al.: First human trial of a DNA bassed vaccine for treatment if human immunodeficiency virus Type I infection: safety and host response. J. Infect. Dis. (1998) 178:92–100.
   PubMed Web of Science ®Google Scholar
• SHROFF KE, MARCUCCI-BORGES LA, DE BRUIN LA I et al: Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunisation by both parenteral and mucosal administration. Vaccine (1999) 18:222–230.
   PubMed Web of Science ®Google Scholar
• COREY L, LANGENBERG AG, ASHLEY R et al.: Recombi-nant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 282:331–340.
   PubMed Web of Science ®Google Scholar
• KOHL S, CHARLEBOIS ED, SIGOUROUDINIA M et al: Limited antibody-dependant cellular cytotoxicity antibody response induced by a Herpes simplex virus Type 2 subunit vaccine. J. Infect. Dis. (2000) 181:335–339.
   PubMed Web of Science ®Google Scholar
• CALAROTA S, BRATT G, NORDLUND S et al.: Cellular cytotoxic response induced by DNA vaccination in hiv-1-infected patients. Lancet (1998) 351:1320–1325.
   PubMed Web of Science ®Google Scholar
• WANG R, DOOLAN DL, LE TP et al: Induction of antigen specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science (1998) 282:476–480.
   PubMed Web of Science ®Google Scholar
• ••A clinical trial that predicts good efficacy of DNA vaccinesagainst malaria.
   Google Scholar
• RUBIN J, GALANIS E, PITOT HC et al.: Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7. Gene Therapy (1997) 4:419–425.
   PubMed Web of Science ®Google Scholar
• STOPECK AT, HERSH EM, AKPORIAYE ET et al.: Phase Istudy of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. J. Clin. Oncol (1997) 15:341–349.
   PubMed Web of Science ®Google Scholar
• ZHU D, SPELLERBERG MB, THOMPSETT A et al.: DNA vaccination as cancer immunotherapy. Biochem. Soc. Transactions (1997) 25:743–747.
   PubMed Web of Science ®Google Scholar
• KING CA, SPELLERBERG MB, ZHU D et al: DNA vaccines with single chain FV fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nature Med. (1998) 4:1281–1286.
   PubMed Web of Science ®Google Scholar
• NICHOLS WW, LEDWITH BJ, MANAM SV, TROILO PJ: Potential DNA vaccine integration into host cell genome. Ann. NY Acad. Sci. (1995) 772:30–39.
   PubMed Web of Science ®Google Scholar
• NAFTZGER C, TAKECHI Y, KOHDA H, VIJAYASARADHI S, HOUGHTON AN: Immune response to a differentiation antigen induced by altered antigen: a study of tumour rejection and autoimmunity. Proc. Natl. Acad. Sci. USA (1996) 93:14809–14814.
   PubMed Web of Science ®Google Scholar
• WEBER LW, BROWNE WB, WOLCHOK JD et al.: Tumor immunity and autoimmunity induced by immunisa-tion with homologous DNA. J. Clin. Invest. (1998) 102:1258–1264.
   PubMed Web of Science ®Google Scholar
• SCHULZ J, PAVLOVIC J, STRACK B, NAWRATH M, MOELLING K: Long-lasting anti-metstatic efficiency of interleukin 12-encoding plasmid DNA. Hum. Gene Ther. (1999) 10:407–417.
   PubMed Web of Science ®Google Scholar
• NAWRATH M, PAVLOVIC J, DUMMET R et al.: Reducedmelanoma tumor formation in mice immunized with DNA expressing the melanoma-specific antigen gp100/pme117. Leukaemia (1999) 13:S48–S51.
   PubMed Web of Science ®Google Scholar